Phase II Study of Lapatinib in Recurrent or Metastatic Epidermal Growth Factor Receptor and/or erbB2 Expressing Adenoid Cystic Carcinoma and Non–Adenoid Cystic Carcinoma Malignant Tumors of the Salivary Glands (Q57272626)
Jump to navigation
Jump to search
article by Mark Agulnik et al published September 2007 in Journal of Clinical Oncology
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II Study of Lapatinib in Recurrent or Metastatic Epidermal Growth Factor Receptor and/or erbB2 Expressing Adenoid Cystic Carcinoma and Non–Adenoid Cystic Carcinoma Malignant Tumors of the Salivary Glands |
article by Mark Agulnik et al published September 2007 in Journal of Clinical Oncology |
Statements
Phase II Study of Lapatinib in Recurrent or Metastatic Epidermal Growth Factor Receptor and/or erbB2 Expressing Adenoid Cystic Carcinoma and Non–Adenoid Cystic Carcinoma Malignant Tumors of the Salivary Glands (English)
0 references
September 2007
0 references
25
0 references
25
0 references
3978-3984
0 references